Gregory Zante
Director of Finance/CFO bij VIKING THERAPEUTICS, INC.
Vermogen: 17 M $ op 31-03-2024
Actieve functies van Gregory Zante
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
VIKING THERAPEUTICS, INC. | Director of Finance/CFO | 04-01-2021 | - |
Investor Relations Contact | - | - | |
Comptroller/Controller/Auditor | 15-02-2021 | - | |
Chief Operating Officer | 01-12-2016 | 01-08-2019 | |
Public Communications Contact | 05-01-2016 | - | |
Corporate Officer/Principal | 01-08-2019 | 04-01-2021 |
Loopbaan van Gregory Zante
Eerdere bekende functies van Gregory Zante
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Director of Finance/CFO | 01-01-2013 | 01-01-2016 |
SANGAMO THERAPEUTICS, INC. | Chief Administrative Officer | 01-08-2003 | 01-06-2013 |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Corporate Officer/Principal | 01-10-1995 | 01-12-2001 |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01-10-1993 | 01-11-1995 |
Opleiding van Gregory Zante
University of California, Los Angeles | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Duitsland | 2 |
2 |
Operationeel
Director of Finance/CFO | 3 |
Corporate Officer/Principal | 3 |
Chief Administrative Officer | 2 |
Sectoraal
Health Technology | 4 |
Commercial Services | 2 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
SANGAMO THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Viking Therapeutics, Inc. | |
Aerami Therapeutics, Inc.
Aerami Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aerami Therapeutics, Inc. develops inhaled insulin products to treat diabetes patients. Its product Dance 501 is designed to produce consistently sized particles of liquid insulin in the form of a smooth mist, allowing the efficient and consistent delivery of insulin into the lungs in a few comfortable breaths. The company was founded by John Stuart Patton in February 9, 2009 and is headquartered in Durham, NC. | Health Technology |
- Beurs
- Insiders
- Gregory Zante
- Ervaring